ask="41.48"
ask_size="500"
average_daily_volume="1255710"
bid="40.20"
bid_size="100"
book_value="11.83"
change="+0.17"
change_from_200_day_moving_average="-12.00"
change_from_50_day_moving_average="0.48"
change_from_52_week_high="-39.48"
change_From_52_week_low="9.25"
change_in_percent="+0.42%"
close="40.63"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.79"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-4.93"
ex_dividend_date="N/A"
float_shares="70877000"
high="40.92"
high_52_weeks="80.11"
last_trade_date="2/8/2017"
last_trade_price="40.63"
last_trade_size="53038"
last_trade_time="4:00pm"
low="39.66"
low_52_weeks="31.38"
market_capitalization="3.49B"
moving_average_200_day="52.63"
moving_average_50_day="40.15"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="64.33"
open="40.17"
pe_ratio="N/A"
peg_ratio="-0.18"
percent_change_from_200_day_moving_average="-22.80%"
percent_change_from_50_day_moving_average="+1.20%"
percent_change_from_52_week_high="-49.28%"
percent_change_from_52_week_low="+29.48%"
previous_close="40.46"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.42"
price_per_sales="93.19"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="8.69"
stock_exchange="NMS"
symbol="ALNY"
volume="1188787"
weeks_range_52="31.38 - 80.11"
